Skip to main content
Professionals
Capabilities
Insights
Locations
Our Firm
News
Events
Careers
search menu
Search
English
Deutsch
English (United Kingdom)
español
עברית
italiano
日本語
한국어
Nederlands
polski
português
中文
Search
submit search
{{typeahead}}
2006
Published Article
Discovery of Aminoquinazolines as Potent, Orally Bioavailable Inhibitors of Lck: Synthesis, SAR, and in Vivo Anti-Inflammatory Activity
Capabilities
Life Sciences & Medical Technology
Offices
Boston
Share
John Buchanan co-authored an article in the
Journal of Medicinal Chemistry
titled "Discovery of Aminoquinazolines as Potent, Orally Bioavailable Inhibitors of Lck: Synthesis, SAR, and in Vivo Anti-Inflammatory Activity."
You May Also Be Interested In:
March 14, 2023 - March 15, 2023
Event
MedTech Intelligence's ConnectedCare Summit East
Washington, D.C.
January 31, 2023, 12:00 PM - 1:30 PM ET
Event
Mainstream and Digital Marketing of your Start-up Life Science Venture
January 31, 2023, 11:00 AM - 12:00 PM ET
Event
Trends in Digital Health & AI